Nasdaq

Agilent Receives Approval for GenetiSure Dx Postnatal Assay in Japan

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) announced it has obtained clearance from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the GenetiSure Dx ...
Nasdaq

Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal ...
FierceBiotech

TRADE NEWS: Five-Nation Breast Cancer Study Chooses Agilent Technologies Microarrays as Primary Genomic Screening Tool

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that the United States-Latin American Cancer Research Network (US-LACRN) has selected Agilent Gene Expression ...
Business Wire

Agilent Technologies and Partners HealthCare Announce Technology Supply Agreement for Mass General, Brigham and Women's Hospitals

PALO ALTO, Calif. & BOSTON--(BUSINESS WIRE)--April 13, 2004--Agilent Technologies Inc. (NYSE:A) and Partners HealthCare System today announced a one-year agreement for Agilent to provide microarray ...
EurekAlert!

Agilent Technologies announces breakthrough for cancer researchers studying chromosomal changes

PALO ALTO, Calif., Jan. 5, 2005 -- Agilent Technologies Inc. (NYSE: A) today announced a breakthrough development that enables the rapid advance of microarray-based comparative genomic studies in ...